by HBOT News | Sep 6, 2011 | Clinical Trials, HBOT Research, Multiple Myeloma
The purpose of this study is to evaluate the safety and efficacy of hyperbaric oxygen therapy
(HBOT) as a therapeutic option in mobilizing stem cells for autologous stem cell transplant.
by HBOT News | Mar 30, 2011 | Chronic Heart Failure
Abstract: Stem-cell transplantation to treat acute myocardial infarction (MI) is gaining importance as a minimally invasive and potent therapy to replace akinetic scar tissue by viable myocardium. Our recent studies have shown that stem-cell transplantation marginally...
by HBOT News | Mar 3, 2011 | Diabetic Foot Ulcers
Abstract: Diabetic patients undergoing hyperbaric oxygen therapies (HBO(2)T) for refractory lower extremity neuropathic ulcers exhibit more than a twofold elevation (p=0.004) in circulating stem cells after treatments and the post-HBO(2)T CD34(+) cell population...
by HBOT News | Jul 13, 2010 | Carcinoma
Abstract: TNF-related apoptosis-inducing ligand (TRAIL, Apo2L) is a promising anticancer agent with high specificity for cancer cells. Many strategies have been proposed to enhance the sensitivity of cancer cells to TRAIL-mediated apoptosis, including the use of...
by HBOT News | Feb 1, 2009 | Diabetes, Key Crohn's Disease Research, Key Stem Cell Research, Radiation
We hypothesized that oxidative stress from hyperbaric oxygen (HBO2, 2.8 ATA for 90 min daily) exerts a trophic effect on vasculogenic stem cells.
The efficacy of hyperbaric oxygen (HBO2) for healing refractory wounds in diabetic patients and those with radiation injuries has been shown in randomized trials, and its utilization is supported by independent evidence-based reviews (6, 10, 20, 32, 38). Mechanisms of action for HBO2 are not clear. The goal of this study was to examine the impact of HBO2 on vasculogenic stem cells in an in vivo animal model.
